John A. Kemp - Concepedia

Author

John A. Kemp

Roche (Switzerland)

Also Known As

A Bourson, Hartmuth Kolb, Helmut Jacobsen, J A Kemp, J A Kemp,, J Kemp, J. A. KEMP, J. A. Kemp, J. Kemp, J.A Kemp

154

Publications

12.1K

Citations

H-Index

135

Concepts

All Affiliations

Roche (Switzerland)Merck & Co., Inc., Rahway, NJ, USA (United States)MSD (UK) Limited (United Kingdom)Janssen (Belgium)

About

John A. Kemp is an author at Roche (Switzerland) specializing in medicine, neuroscience, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	46	74	7.7K
2	Social Sciences	27	34	3.3K
3	Natural Sciences	9	9	720
4	Health Sciences	8	8	533
5	Public Health	2	2	179

John A. Kemp

108

Publications

10.5K

Citations

H-Index

Page 1

	Year	Citations
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis Mark B. Pepys, J. Herbert, W. L. Hutchinson, Nature Alzheimer's DiseaseMedicinePharmacological DepletionNeurochemical BiomarkersProtein Misfolding	2002	536
7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. John A. Kemp, Alan C. Foster, Paul D. Leeson, Proceedings of the National Academy of Sciences NeurotransmitterNeurotransmissionCellular PhysiologySocial SciencesSelective Antagonist	1988	520
Non-competitive antagonists of excitatory amino acid receptors John A. Kemp, Alan C. Foster, Erik H.F. Wong Trends in Neurosciences Functional SelectivityMedicinePhysiologyNeuropharmacologyNon-peptide Ligand	1987	499
Ro 25–6981, a Highly Potent and Selective Blocker of N-Methyl-d-aspartate Receptors Containing the NR2B Subunit. Characterization in Vitro G. Fischer, Vincent Mutel, Gerhard Trube, Journal of Pharmacology and Experimental Therapeutics	1997	482
Cholinergic modulation of the functional organization of the cat visual cortex Adam M. Sillito, John A. Kemp Brain Research Neurobiological MechanismCognitive ScienceCat Visual CortexNeural MechanismFunctional Organization	1983	390
A re-evaluation of the mechanisms underlying simple cell orientation selectivity Adam M. Sillito, John A. Kemp, James A. Milson, Brain Research OptogeneticsDevelopmental BiologySignal TransductionMedicineCell Interaction	1980	262
A novel mechanism of activity‐dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. James N.C. Kew, Gerhard Trube, John A. Kemp The Journal of Physiology	1996	238
Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site Frédéric Knoflach, Vincent Mutel, Synèse Jolidon, Proceedings of the National Academy of Sciences Mglu1 Receptor ResponsesSignal TransductionMolecular PhysiologyBiochemistryG Protein-coupled Receptor	2001	236
Developmental Changes in NMDA Receptor Glycine Affinity and Ifenprodil Sensitivity Reveal Three Distinct Populations of NMDA Receptors in Individual Rat Cortical Neurons James N.C. Kew, J. G. Richards, Vincent Mutel, Journal of Neuroscience Synaptic TransmissionNeurotransmitterNeurotransmissionNr2b MrnaSocial Sciences	1998	224
CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice Renzo Mancuso, Gemma Fryatt, Madeleine Cleal, Brain ImmunologyCell DeathNeurochemical BiomarkersNeuroinflammationInflammation	2019	224

Page 1